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Diabetes-induced microvascular dysfunction in the hydro- Early, uncomplicated diabetes is characterized by
nephrotic kidney: Role of nitric oxide. chronic vasodilation and hyperperfusion in various vas-
Background. Renal hemodynamics in early diabetes are cular beds, including the skin [1], forearm [2], cerebralcharacterized by preglomerular and postglomerular vasodila-
[3], and mesenteric [4] circulation of both experimentaltion and increased glomerular capillary pressure, leading to
animals and humans. The resulting microvascular hyper-hyperfiltration. Despite intensive research, the etiology of the
renal vasodilation in diabetes remains a matter of debate. The tension has been suggested to lead to capillary sclerosis
present study investigated the controversial role of nitric oxide with ultimately a decrease of tissue perfusion.
(NO) in the renal vasodilation in streptozotocin-induced dia- In the diabetic kidney, the early hemodynamic alter-betic rats.
ations are characterized by the development of hyperfil-Methods. In the renal microcirculation, basal tone and re-
tration. Micropuncture studies have demonstrated thatsponse to NO synthase blockade were studied using the in vivo
hydronephrotic kidney technique. l-arginine analog N-nitro- the increase in glomerular filtration rate is associated
l-arginine methyl ester (L-NAME) was administered locally with glomerular hyperperfusion, caused by a reduction
to avoid confounding by systemic blood pressure effects. The
in the intrarenal vascular resistance, and with glomerularexpression of endothelial NO synthase (eNOS) was investi-
capillary hypertension, resulting from a proportionallygated in total kidney by immunocytochemistry and in isolated
renal vascular trees by Western blotting. Urinary excretion of greater reduction in preglomerular versus postglomeru-
nitrites/nitrates was measured. lar resistance [5, 6].
Results. Diabetic rats demonstrated a significant basal vaso- Despite intensive research, the etiology of the diabe-
dilation of all preglomerular and postglomerular vessels versus
tes-induced renal vasodilation remains a matter of de-control rats. Vasoconstriction to L-NAME was significantly
bate. Some observations have suggested an increasedincreased in diabetic vessels. After high-dose L-NAME, there
was no difference in diameter between diabetic and control generation or action of nitric oxide (NO) as a mediator
vessels, suggesting that the basal vasodilation is mediated by of hyperfiltration in early experimental diabetes. Acute
NO. Immunocytochemically, the expression of eNOS was systemic infusion of NO synthase blockers caused a moremainly localized in the endothelium of preglomerular and post-
pronounced decrease in glomerular filtration rate andglomerular vessels and glomerular capillaries, and was in-
renal plasma flow in diabetic rats, largely eliminating thecreased in the diabetic kidneys. Immunoblots on isolated renal
vascular trees revealed an up-regulation of eNOS protein ex- difference between diabetic and control animals [7–9].
pression in diabetic animals. The urinary excretion of nitrites/ Similarly, chronic oral administration of l-arginine analog
nitrates was elevated in diabetic rats. N-nitro-l-arginine methyl ester (L-NAME) preventedConclusion. The present study suggests that an up-regula-
the development of hyperfiltration in diabetic animalstion of eNOS in the renal microvasculature, resulting in an
increased basal generation of NO, is responsible for the intra- [10]. An increased expression of endothelial NO syn-
renal vasodilation characteristic of early diabetes. thase (eNOS) was recently documented in glomerular
endothelial cells and preglomerular vessels of diabetic
rats [9, 11]. However, the data concerning the effect
of experimental diabetes on renal NO production are
conflicting. In contrast to the previously mentioned stud-Key words: eNOS, glomerular blood flow, renal hemodynamics, vaso-
dilation. ies, a similar renal vasoconstriction and decrease in renal
plasma flow was reported after acute NOS blockade inReceived for publication July 26, 2000
diabetic and control rats [12, 13]. Furthermore, a reducedand in revised form February 7, 2001
Accepted for publication February 9, 2001 basal generation of cGMP was reported in isolated glo-
meruli of diabetic rats [14, 15]. Finally, a blunted vaso- 2001 by the International Society of Nephrology
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constriction in response to systemic NOS blockade was scribed previously in detail [18, 19]. In brief, female Wistar
rats (200 to 220 g) were anesthetized with halothane (Fluo-observed in diabetic as compared with control kidneys,
suggesting a decreased NO-mediated influence [16, 17]. thane, Zeneca, Destelbergen, Belgium), and a unilateral
hydronephrosis was induced by a permanent ligation ofIt should be noted that in all reported studies the NOS
blockade, even when administered intrarenally, resulted the left ureter. Approximately 8 to 10 weeks following
the induction of hydronephrosis, the renal parenchymain systemic blood pressure changes, with potential con-
founding effects on renal hemodynamics. became a thin translucent tissue sheet due to tubular
atrophy. The microcirculation remains intact [20, 21], how-Insight into the mechanisms underlying the early he-
modynamic changes in the diabetic kidney is particularly ever, and is accessible for study by intravital microscopy.
For the final experiments, the rats were anesthetized withimportant, since they are a risk factor for the subsequent
development of microalbuminuria and overt diabetic ne- thiobutabarbital (100 mg/kg IP; Inactin; RBI, Natick, MA,
USA). The trachea was intubated, and a jugular veinphropathy [6]. The present report attempts to address
the controversy on the role of NO in the early renal was cannulated with a double polyethylene catheter for
continuous infusion of isotonic saline (3 mL/hour). Ahemodynamic changes in diabetes. An intravital micros-
copy technique was used to allow the direct visualization carotid artery was cannulated for continuous monitoring
of mean arterial blood pressure. The hydronephroticof the renal microcirculation with measurement of vascu-
lar diameters and glomerular blood flow (GBF). Impor- kidney was exposed by a left flank incision and split with
a thermal cautery along its greater curvature. The ventraltantly, NOS inhibition was administered topically, thereby
avoiding interference by intrarenal autoregulatory mech- half of the kidney was sutured to a semicircular frame
and attached to the bottom of a plexiglas bath. The entryanisms. In addition to these functional studies, an immu-
nocytochemical and molecular evaluation of the expres- of the renal hilus into the bath was sealed with silicone
grease, and the bath was filled with an isotonic, isocolloi-sion of NOS in the renal microcirculation was performed.
dal solution (Haemaccel, Hoechst Marion Roussel, Mar-
burg/Lahn, Germany) and maintained at 37C. Glomer-
METHODS
uli and renal vessels were visualized by transillumination
Laboratory animals microscopy (Axiotech Vario 100 HD; Zeiss, Jena, Ger-
many) using water-immersion objectives (AchroplanThe studies were performed in female Wistar rats (Iffa
Credo, Brussels, Belgium) that received care in accor- 10, 40, 63). The resulting image was displayed on
a television monitor by a video camera (Kodak Motion-dance with the national guidelines for animal protection.
Diabetes was induced by an intravenous injection of strep- corder Analyzer; Eastman Kodak Company, San Diego,
CA, USA) and recorded on videotape (S-VHS Pana-tozotocin (65 mg/kg; Pfanstiel Europe Ltd., Davenham,
UK). Only animals with blood glucose values above 14 sonic AG-7355, Matsushita, Japan) for off-line analysis
using image analysis software (Capimage, Ingenieurbu¨rommol/L were included in the experiments. Slow release
insulin implants (Linshin, Scarborough, Canada) with a Zeintl, Heidelberg, Germany).
The renal vessels were identified according to theirrelease rate of 1 U/24 h were used to maintain moderate
hyperglycemia. In the rats with a hydronephrotic kidney branching pattern from a selected glomerulus. The luminal
diameters of the following vascular segments were mea-(discussed later in this article), diabetes was induced
eight weeks after the ureter ligature. Age-matched con- sured: proximal arcuate artery (near the interlobar artery),
distal arcuate artery (near the interlobular artery), proxi-trol rats were run in parallel with the diabetic groups.
Experiments were carried out six weeks after the induc- mal interlobular artery (near the arcuate artery), distal
interlobular artery (near the afferent arteriole), proximaltion of diabetes. At the beginning of each experiment,
plasma samples were drawn for analysis of glucose, fruc- afferent arteriole (near the interlobular artery), distal
afferent arteriole (the narrowest segment before enter-tosamine, total protein, and cholesterol levels.
A total of 60 rats was used: 16 rats for intravital micros- ing the glomerulus), proximal efferent arteriole (within
50 m of the glomerulus), and distal efferent arteriolecopy, 12 rats for immunohistochemistry, 16 rats for deter-
mination of the optimal isolation procedure of the renal (near the first branching). At least two to three specimens
of each of these vessel types were selected for study.vascular trees, and 16 rats for immunoblots on the renal
vascular trees and determination of urinary nitrate/nitrite Red blood cell velocity was measured in the efferent
arteriole using the line-shift-diagram method [22]. Glo-excretion. Hydronephrosis was induced only in the con-
trol and diabetic rats used for intravital microscopy. merular blood flow was calculated from the red blood
cell velocity and the luminal diameter of the efferent
Induction of hydronephrosis, preparation of the arteriole.
hydronephrotic kidney, and intravital microscopy The kidneys were allowed to stabilize in the tissue
bath for one hour after completion of surgery, beforeThe techniques for induction of hydronephrosis and
preparation of the hydronephrotic kidney have been de- two control measurements of vascular diameters and
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GBF were made. A dose–response curve to locally ap- were gently rubbed against the grids and washed with
ice-cold PBS. With this procedure, the renal parenchymaplied L-NAME (105 to 104 mol/L; Sigma Chemical
Co., St. Louis, MO, USA) was performed in diabetic (N passes through the mesh, whereas the vascular tree is
retained on the grid and can be picked up by a forceps.8) and control rats (N  8). The upper limit of the dose–
response curve was selected on the basis of pilot experi- To determine the optimal purification procedure, three
successive levels of purity were obtained in a separatements, demonstrating that L-NAME concentrations
higher than 104 mol/L did not cause further reductions group of 16 control rats by progressively applying more
and longer force. The highest level of purity was subse-of vascular diameter in both control and diabetic rats.
quently selected as the optimal procedure and used to
Immunocytochemistry for eNOS isolate the renal vascular trees of a third group of control
(N  8) and diabetic rats (N  8).The location of eNOS in the kidneys was investigated
using indirect immunocytochemistry. The kidneys of a The vascular trees were snap frozen in liquid nitrogen.
Each sample contained both kidneys of two rats, yieldingsecond group of diabetic (N  6) and control rats (N 
6) were rinsed by retrograde aortic perfusion with phos- four samples in each group. The samples were finely
ground to be suspended in (2 mL/g of tissue) ice-coldphate-buffered saline (PBS) and snap frozen in melting
isopentane cooled by liquid nitrogen. Five-micrometer homogenization buffer [50 mmol/L Tris, pH 7.4, containing
0.1 mmol/L egtazic acid (EGTA), 0.1 mmol/L ethylenedi-frozen sections were prepared with a 2800 Frigocut E
cryostat microtome (Reichert-Jung GmbH, Nussloch, aminetetraacetic acid (EDTA), 2 mmol/L -mercapto-
ethanol, 5 mol/L leupeptin, and 4 mol/L pepstatin].Germany) and fixed in acetone for 10 minutes. Nonspe-
cific antibody staining was blocked by incubation with The suspension was homogenized with three passes of P6
Ultra-Turrax (Labortechnik, Staufen, Germany) andPBS containing 0.2% cold water fish gelatin (Sigma),
2% bovine serum albumin (BSA; Sigma), and 2% fetal briefly sonicated (BransonSonifier B12, Danbury, CT,
USA). The resulting homogenate was centrifuged atcalf serum (FCS; Sigma) for 30 minutes at room tempera-
ture. Incubation with a mouse monoclonal antibody 6000 g for 10 minutes at 4C. The postnuclear superna-
tant (total protein extract) was kept, and protein concen-against human eNOS isotype IgG1 (Transduction Labo-
ratories, Lexington, KY, USA) diluted 1:1000 in PBS trations were determined using the Bradford method
(Bio-Rad, Melville, NY, USA) with BSA as standard.containing fish gelatin was carried out overnight at 4C.
Antibody binding was visualized with Cy3-conjugated The samples were then stored at 80C until use.
Sodium dodecyl sulfate-polyacrylamide gel electro-goat anti-mouse IgG antibody (Jackson Laboratories,
West Grove, PA, USA). Sections were mounted and phoresis (SDS-PAGE) and immunoblotting were per-
formed as described [24]. Briefly, the extracts were solu-viewed with a Polyvar fluorescent microscope (Reichert-
Jung). The specificity of the immunolabeling was con- bilized by heating (95C for 2 min) in sample buffer [1.5%
SDS, 10 mmol/L Tris-HCl, pH 6.8, 0.6% DL-dithiothre-firmed by incubation without primary antibody and by
incubation with nonspecific antibody. Some sections itol, and 6% (vol/vol) glycerol], and 40 g were loaded
on the gels. Proteins were separated by PAGE throughwere stained with hematoxylin and eosin for routine
morphological evaluation. 0.1  9  6 cm 7.5% acrylamide slabs and transferred
to nitrocellulose. The membranes were blocked for 30The intensity of the eNOS antibody staining in the
diabetic and control kidneys was evaluated by two inde- minutes at room temperature in blotting buffer (50 mmol/L
NaPO4, 150 mmol/L NaCl, 0.05% Tween 20, pH 7.4)pendent investigators unaware of the status of the ani-
mals. In the glomeruli, an additional semiquantitative comprising 5% nonfat dry milk, followed by incubation
with a mouse monoclonal antibody against human eNOSevaluation of antibody staining was performed. For each
kidney, 20 glomerular profiles, cut in equatorial section (Transduction Laboratories), diluted in blotting buffer
containing 2% BSA at 4C for 16 to 18 hours. The mem-planes and successively appearing in the visual field of
the microscope when moving the section through the branes were then washed and incubated for one hour at
room temperature with a peroxidase-labeled goat anti-entire depth of the cortex, were evaluated. The number
of capillary profiles stained by eNOS antibody was deter- mouse antibody (Dako, Glostrup, Denmark). Immuno-
blots were visualized with enhanced chemiluminescencemined and normalized for glomerular surface area.
(Amersham, Little Chalfont, UK). The specificity of the
Isolation of renal vascular trees and signal was determined by comparison with positive con-
immunoblots for eNOS trols (aortic endothelial lysate) and nonimmune mouse
IgG (Vector Laboratories, Burlingame, CA, USA). Den-For the isolation of the renal vascular trees [23], kid-
neys were resected, decapsulated, and longitudinally bi- sitometry analysis was performed with a StudioStar Scan-
ner (Agfa-Gevaert, Mortsel, Belgium) using the NIH-sected. Kidney halves were pressed with their surface
against stainless steel grids of 50 mesh size, correspond- Image V1-57 software. The relative optical densities (in
percentage of controls) were obtained in duplicate.ing with 300 m openings (Sigma). Renal vascular trees
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Table 1. Characteristics and biochemical parameters in
control and diabetic rats
Control Diabetes
Body weight g 291.42.5 (N22) 263.63.4 (N22)a
Mean arterial blood
pressure mm Hg 122.57.0 (N8)b 123.16.1 (N8)b
Glycemia mg/dL 130.712.2 (N22) 468.955.3 (N22)a
Fructosamine
lmol/g total protein 2.080.13 (N22) 4.080.31 (N22)a
Cholesterol mg/dL 58.44.2 (N22) 66.68.1 (N22)
a P  0.0001 vs. control
b Blood pressure was only measured in the rats examined by intravital mi-
croscopy
Urinary nitrite/nitrate excretion
Diabetic (N 8) and control (N 8) rats were housed
in metabolic cages for 24 hours. The urine was collected
in a sterilized reservoir, containing 100 U penicillin
Fig. 1. Vascular diameters and glomerular blood flow (GBF) in the(Sigma), 5000g streptomycine sulfate (Sigma), and 0.25
hydronephrotic kidney of control (, N  8) and diabetic rats (, N 
g amphotericin B (Sigma). Urine samples were filtered 8) in the basal state (A) and after local application of L-NAME 104
mol/L in the tissue bath (B). 1, proximal arcuate artery; 2, distal arcuatethrough a 10 kD molecular weight cut-off filter (Pall
artery; 3, proximal interlobular artery; 4, distal interlobular artery; 5,Filtron, Northborough, MA, USA). Nitrite and nitrate
proximal afferent arteriole; 6, distal afferent arteriole; 7, proximal effer-
concentrations were determined using a commercially ent arteriole; and 8, distal efferent arteriole. In each kidney, at least
two to three specimens of each vessel type were evaluated. Data areavailable assay kit (Cayman Chemical, Ann Arbor, MI,
expressed as mean  SEM. *P  0.05, control vs. diabetes.USA). Conversion of nitrates to nitrites was performed
with nitrate reductase, and the resulting products (NOx)
were assayed with a fluorimetric method using diamino-
naphtalene. Nitrite levels were subtracted from NOx to NOS blockade. For all vessel types, the vasoconstriction
obtain nitrate concentrations.
after L-NAME was more pronounced in the diabetic
animals (Fig. 2). After the highest L-NAME dose, diame-Statistical analysis
ters and GBF were not different between diabetic andThe data are presented as mean  SEM. For the
control animals (Fig. 1B). Local application of L-NAMEvascular reactivity studies, analysis of variance was used
in the tissue bath was devoid of systemic blood pressureto test overall differences between groups. Unpaired
effects in both control rats (122.5  7.0 mm Hg at base-t tests were further used to test statistical significance
line and 123.1  5.4 mm Hg after L-NAME 104 mol/L)The significance level was set at P  0.05.
and diabetic rats (123.1  6.1 mm Hg at baseline and
121.3  6.9 mm Hg after L-NAME 104 mol/L).
RESULTS
Characteristics of laboratory animals Immunocytochemical demonstration of eNOS
Diabetic animals had significantly lower body weights localization in total kidney
and higher plasma glucose and fructosamine levels com- Positive eNOS staining was detectable in the endothe-
pared with the age-matched control rats (Table 1). Mean lium of all preglomerular vessels (arcuate arteries, inter-
arterial blood pressure and plasma cholesterol levels lobular arteries, afferent arterioles), in glomerular capil-
were not different between diabetic and control rats. laries, and in postglomerular vessels (efferent arterioles,
peritubular capillaries, vascular bundles in the outer me-Intravital microscopy of the hydronephrotic kidney
dulla). As compared with controls, eNOS staining wasBasal diameters of all vessel types and GBF were
clearly more pronounced in diabetic kidneys, particularlyhigher in diabetic rats as compared with control rats (Fig.
in preglomerular and postglomerular vessels and in glo-1A). Application of L-NAME in the tissue bath caused
merular capillaries (Fig. 3). The number of stained glo-a vasoconstrictive response in both animal groups. The
merular profiles normalized for glomerular surface areavasoconstriction to L-NAME was most pronounced in the
was significantly higher in the diabetic glomeruli com-arcuate arteries, whereas afferent arterioles constricted
pared with control glomeruli (13.8  1.4 vs. 9.6  0.5,only moderately in response to L-NAME. Efferent arte-
rioles constricted more than afferent arterioles after P  0.05).
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Fig. 2. Percentage changes of basal vascular diameters (A–D) and GBF (E ) in the hydronephrotic kidney of control (, N  8) and diabetic
rats (, N  8) in response to local application of L-NAME 105 mol/L to 104 mol/L in the tissue bath. In each kidney, at least two to three
specimens of each vessel type were evaluated. The data of proximal and distal segments of each vessel type are pooled. Data are expressed as
mean  SEM. *P  0.05, control vs. diabetes.
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Fig. 3. Immunocytochemical staining for endothelial nitric oxide synthase (eNOS) in control (A) and diabetic (B) kidneys. Staining is detectable
in glomerular capillaries and in afferent and efferent arterioles, visible at the vascular pole of the glomeruli. More capillary profiles are stained in
the diabetic glomerulus.
eNOS expression in renal vascular trees
The expression of eNOS was detected as a single band
at 140 kD, identical to that in bovine aortic endothelial
cells. As compared with the variable signal in whole
kidney extracts, there was a progressive increase in
eNOS expression along with the degree of purification
of the renal vascular trees. The eNOS expression was
consistently higher in highly purified renal vascular trees
(level 3) than in a control pool of aorto-iliac arteries
Fig. 4. Renal vascular trees were isolated by rubbing kidney halves(Fig. 4). As compared with controls, eNOS expression
against stainless steel grids with 300 m openings. Three levels of purifi-
was substantially increased in highly purified vascular cation of the renal vascular trees were obtained by progressively applying
more and longer pressure (kidney vascular tree: 1, lowest purification; 2,trees of diabetic rats (Fig. 5A). Densitometry analysis
intermediate purification; and 3, highest purification). The extracts fromconfirmed a more than twofold increase in eNOS expres- the renal vascular trees were compared with whole kidney extracts and
sion in the diabetic renal vascular trees (Fig. 5B). extracts from a pool of aortas and iliac arteries. The expression of eNOS
was detected as a single band at 140 kD, identical to that in bovine
aortic endothelial cells (lane C). As compared with the variable signalUrinary nitrite/nitrate excretion
in whole kidney extracts, there was a progressive increase in eNOS
The urinary excretion of the stable NO metabolites expression along with the degree of purification of the renal vascular
trees. The eNOS expression was consistently higher in purified renalwas significantly elevated in diabetic rats (N  8) com-
vascular trees than in the pool of aortas and iliac arteries.pared with control rats (N  8). Urinary nitrites were
889.0  153.6 mol/24 h in diabetic and 348.8  42.6
mol/24 h in control rats (P  0.0001). Urinary nitrates
bination of functional and molecular techniques. Renalwere 11529  4500 mol/24 h in diabetic and 4539 
hemodynamics were evaluated by intravital microscopy1411 mol/24 h in control rats (P  0.001).
of the hydronephrotic kidney, a model that allows the
study of the major renal vascular segments and the mea-
DISCUSSION surement of GBF in vivo. The technique visualizes arcu-
The present study addresses the role of NO in the ate arteries, interlobular arteries, afferent arterioles, and
efferent arterioles, the vascular segments that contributerenal hemodynamic changes of early diabetes, with a com-
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vasculature in response to NOS blockade. All of these
studies have been performed in short-term (one to six
weeks) streptozotocin-induced diabetes in rats, making
differences in diabetes model an unlikely source of dis-
parity. Some of the discrepancies may rather be related
to technical issues.
An elevated basal NO generation in the diabetic vas-
culature may require higher doses of l-arginine ana-
logues for complete inhibition. This has typically been
illustrated by the presence of a decreased pressor re-
sponse to low dose L-NAME and a similar pressor re-
sponse to high dose L-NAME in diabetic rats as com-
pared with control rats [7]. Similarly, a blunted increase
of blood pressure and decrease of glomerular filtration
rate in response to an l-arginine analogue in diabetic
rats was associated with a continuing high urinary excre-
tion rate of nitrates/nitrites, suggesting that the same
dose of l-arginine analogue inhibited NO synthesis less
in diabetic rats than in control rats [13]. Therefore, in-
complete blockade of increased NO production, rather
than reduced production of NO, may explain some of
Fig. 5. Immunoblot analysis of eNOS expression in the isolated kidney
the findings of blunted or similar renal vasoconstrictionvascular trees of control (N 8) and diabetic (N 8) rats. Each sample
contains the vascular trees of both kidneys of two rats. A single band in diabetes after NOS inhibition.
at 140 kD, identical to that identified in aortic endothelial lysate (lane In most studies, NOS inhibitors were administered
C) and corresponding with eNOS, is consistently more intense in renal
systemically and resulted in a substantial increase of sys-vascular trees from diabetic rats than in those from control rats (A).
Densitometry analysis demonstrates a significantly higher signal inten- temic blood pressure and, consequently, of renal perfu-
sity in diabetic vs. control vascular trees (B). *P  0.05. sion pressure. A normal kidney responds to an increased
perfusion pressure with autoregulatory vasoconstriction,
which will superimpose on the vasoconstriction induced
by the NO blockade itself. An impaired myogenic vaso-most to total renal vascular resistance [21]. Diabetic rats
constriction in response to increased perfusion pressure,demonstrated a basal vasodilation of all preglomerular
as previously demonstrated in diabetic kidneys [25], mayand postglomerular arterial vessels and an increased
thus offset an increased vasoconstriction to NOS block-GBF, consistent with previous findings of a higher basal
ade, resulting in a similar or smaller decrease in renal
renal blood flow [13, 16] or renal plasma flow [7, 9, 10]
blood flow in diabetic rats, as compared with control
and a lower renal vascular resistance [5, 12] in diabetes. rats. Such a bias was avoided in the present study by
An important advantage of the hydronephrotic kidney the local application of L-NAME. However, differential
technique is the possibility of administering high doses effects of local NOS blockade on myogenic tone [26] in
of vasoactive substances topically, whereby potential in- diabetic and control rats cannot be excluded.
terference by systemic effects with autoregulatory changes Impaired responses to different endothelium-depen-
in the renal microcirculation can be avoided. The admin- dent agonists have been demonstrated in various vascular
istration of L-NAME in the tissue bath resulted in a more beds, including the renal microcirculation, of different mod-
pronounced vasoconstriction of all vessels of diabetic els of diabetes [27]. In several of these studies, impaired
kidneys compared with controls. The highest dose of endothelium-dependent vasodilation was assumed to be
L-NAME decreased vascular diameters to values that caused by an impaired NO-mediated influence, although
were not different between diabetes and control rats. no direct assessment of NO production was performed.
These findings suggest that the basal vasodilation in the It should be noted that agonist-induced endothelial stim-
renal microcirculation can be attributed to an increased ulation also releases NO-independent vasodilating sub-
generation of NO. stances, including prostacyclin and endothelium-derived
The present results are in line with and extend the hyperpolarizing factor (EDHF). A disturbed generation
findings of partial or complete elimination of hyperfil- of EDHF, rather than an impaired NO-mediated vasodi-
tration and hyperperfusion in diabetic rats by oral [10], lation, has been demonstrated to be responsible for the
systemic [7, 9], or intrarenal [8] NOS blockade. However, decreased vascular responsiveness to acetylcholine in di-
they contrast with other reports of a similar [12, 13] abetes [28, 29]. In addition, a distinction should be made
between basal and stimulated release of endothelium-and even blunted [16, 17] vasoconstriction of the renal
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derived relaxing factors. An attenuated response to an eNOS expression by increasing the intracellular calcium
endothelium-dependent agonist may reflect an already concentration [35, 36]. Vascular endothelial growth fac-
increased basal generation of NO that cannot be stimu- tor (VEGF) is known to stimulate NO production in
lated further, as has been demonstrated in postischemic endothelial cells [37]. In experimental diabetes, the ex-
kidneys [30]. Taken together, the finding of impaired pression of VEGF in visceral epithelial cells [38, 39] and
endothelium-dependent vasodilation does not necessar- of VEGF receptors in endothelial cells of glomerular
ily exclude the presence of an elevated basal production capillaries and preglomerular and postglomerular vessels
of NO. is up-regulated [38]. VEGF blockade was found to pre-
Although the use of the split hydronephrotic kidney vent renal dysfunction as well as up-regulation of eNOS
model in the present setup has several advantages for in diabetic kidneys [40], thus pointing to VEGF as an
the study of vascular reactivity in vivo, it should be noted alternative mediator of the increased eNOS expression
that the model also has limitations. The absence of tubu- in the diabetic kidney.
lar structures does not allow examination of the potential In summary, an increased NO production in the renal
contribution of tubular reabsorption and tubuloglomeru- microcirculation may mediate intrarenal vasodilation
lar feedback in the pathogenesis of diabetic hyperfiltration and increased GBF in streptozotocin-induced diabetic
[31]. Although vascular reactivity in the hydronephrotic rats. Our results further suggest that the elevated NO
kidney corresponds well with results obtained by other generation results from an up-regulation of eNOS in the
approaches [21], it cannot be entirely excluded that the renal microvasculature.
vascular response to hyperglycemia is altered by the de-
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